Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

20.36 +1.53 (+8.13%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Why Petros Pharmaceuticals Stock Is Soaring Today
Petros Pharmaceuticals Inc (NASDAQ: PTPI) is trading higher Wednesday after the company announced 476% growth year-over-year of STENDRA tablet sales as part of its digital... 
Via Benzinga
Kevin Durant Launching A SPAC That Could Target Sports Or Cryptocurrency
One of the biggest National Basketball Association stars is dipping his toes into the SPAC market, becoming the latest celebrity or athlete to atta... 
Via Benzinga
Hims & Hers Expands Support for Men’s Sexual Wellness With Introduction of Climax Delay Wipes
From Hims & Hers Health, Inc.
Via Business Wire
November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,... 
Via Benzinga
Hims & Hers Health, Inc. to Announce Third Quarter 2021 Financial Results and Host Conference Call
From Hims & Hers Health, Inc.
Via Business Wire
Vitamin Shoppe To Offer Haircare Products From Hims & Hers
Hims & Hers Health Inc (NYSE: HIMS) has partnered with The Vitamin Shoppe, a subsidiary of Franchise Group Inc (NASDAQ: FRG), to make its products... 
Via Benzinga
Hims & Hers Partners with The Vitamin Shoppe To Expand Availability Of Personal Care Offerings To Over 280 Stores and Online Across the U.S.
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Expands Customizable, Compounded Skincare Offerings With Hims Overnight Anti-Aging Duo, Hers Clear Skin System
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Launches Supplement Powder To Support Urinary Tract Health
Hims & Hers Health Inc (NYSE: HIMS) has expanded its women's health offerings by launching a D-Mannose dietary supplement powder to support urinary tract... 
Via Benzinga
Hims & Hers Expands Women’s Health Offerings With Support For Urinary Tract Health
From Hims & Hers Health, Inc.
Via Business Wire
Revolve To Offer Hims & Hers Health Products
Telehealth platform Hims & Hers Health Inc (NYSE: HIMS) has announced a partnership with Revolve Group Inc (NYSE: RVLV). Revolve will add a... 
Via Benzinga
Hims & Hers Partners with REVOLVE to Help More Consumers Access High Quality, Personalized Health and Wellness Solutions
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health to Present at Upcoming Financial Conferences
From Hims & Hers Health, Inc.
Via Business Wire
3 High-Growth Healthcare Stocks to Buy in September
All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector. 
Via The Motley Fool
2 Top Growth Stocks That Beat Expectations and Raised Guidance
Both grew their sales by more than 50% in their most recent quarters. 
Via The Motley Fool
Gronk Spike: Hims & Hers Signs Rob Gronkowski To Partnership
One of the most well-known NFL players is partnering with a health care company to bring awareness to men’s health issues and treatment. What Happened: Tampa Bay Buccaneers... 
Via Benzinga
Hims & Hers Health CFO To Step Down; Reaffirms Outlook
Hims & Hers Health Inc (NYSE: HIMS) has announced that Spencer Lee will step down as its Chief Financial Officer. Lee will lead a six-month transition plan and... 
Via Benzinga
Hims & Hers Partners With Rob Gronkowski to Bring Awareness to Men’s Health Issues and Treatment
From Hims & Hers Health, Inc.
Via Business Wire
Spencer Lee to Step Down as Hims & Hers Health Chief Financial Officer
From Hims & Hers Health, Inc.
Via Business Wire
Following Strong Growth, Hims & Hers Appoints Chief Growth Officer
From Hims & Hers Health, Inc.
Via Business Wire
What UnitedHealth's Big Move Means for These Telehealth Stocks
UnitedHealth is moving into direct-to-consumer healthcare. What does the prospect of a giant new competitor mean for Teladoc and Hims & Hers Health? 
Via The Motley Fool
What the Market Is Missing About Hims & Hers Health
This stock's share price is not matching up with the company's underlying performance. Let's investigate. 
Via The Motley Fool
Why Hims & Hers Health Fell by Nearly 11% Today
New week, new price target decrease from an analyst. 
Via The Motley Fool
Why Hims & Hers Health Shares Are Trading Higher Today
Hims & Hers Health Inc (NYSE: HIMS) is trading higher Thursday after the company announced better-than-expected second-quarter financial results and issued guidance above... 
Via Benzinga
Why Hims & Hers Health Stock Popped Today
Shares of the telehealth company rose on better-than-expected second-quarter results. 
Via The Motley Fool
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Hims & Hers Stock Shoot Up - What You Need To Know
A multi-specialty telehealth platform provider, Hims & Hers Health Inc (NYSE: HIMS), reported Q2 sales increased 69% Y/Y to $60.7 million, beating the... 
Via Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million.... 
Via Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.